A-SPINE Asia Co., Ltd. (TPEX:6758)
Taiwan · Delayed Price · Currency is TWD 29.00
+0.65 (2.29%)
Jun 5, 2026, 9:22 AM CST
A-SPINE Asia Market Cap
A-SPINE Asia has a market cap or net worth of 390.66 million as of June 5, 2026. Its market cap has decreased by -27.14% in one year.
Market Cap
390.66M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.00
Market Cap Chart
Since January 2, 2020, A-SPINE Asia's market cap has decreased from 1.20B to 390.66M, a decrease of -67.42%. That is a compound annual growth rate of -16.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 381.90M | -28.23% |
| Dec 31, 2025 | 532.11M | -1.00% |
| Dec 30, 2024 | 537.49M | 2.57% |
| Dec 29, 2023 | 524.02M | 2.37% |
| Dec 30, 2022 | 511.90M | -19.23% |
| Dec 10, 2021 | 633.81M | -18.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rossmax International | 1.18B |
| Wiltrom | 1.02B |
| S&S Healthcare Holding | 911.28M |
| Radiant Innovation | 811.90M |
| PlexBio | 806.39M |
| Carilex Medical | 687.29M |
| AmCad BioMed | 677.66M |
| Health & Life | 568.89M |